In addition, the ectopic expression of PD-L1 promotes TGF-β-mediated EMT and EGFR-TKI resistance in NSCLC cells through upregulating Smad3 phosphorylation [144]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.